162 related articles for article (PubMed ID: 32850336)
41. DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.
Zheng Q; Gu X; Yang Q; Chu Q; Dai Y; Chen Z
Clin Chim Acta; 2021 Jun; 517():1-8. PubMed ID: 33607068
[TBL] [Abstract][Full Text] [Related]
42. DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA.
Hu C; Liu K; Wang B; Xu W; Lin Y; Yuan C
Curr Pharm Des; 2021; 27(9):1211-1218. PubMed ID: 33121401
[TBL] [Abstract][Full Text] [Related]
43. Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1.
Li X; Zhang H; Wu X
Gene; 2019 Feb; 686():1-7. PubMed ID: 30366080
[TBL] [Abstract][Full Text] [Related]
44. Strategies of LncRNA DLX6-AS1 on Study and Therapeutics.
Zhao Y; Li P
Front Genet; 2022; 13():871988. PubMed ID: 35719380
[TBL] [Abstract][Full Text] [Related]
45. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression
Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H
Front Genet; 2020; 11():1030. PubMed ID: 33101368
[TBL] [Abstract][Full Text] [Related]
46. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers.
Alizadeh A; Jebelli A; Baradaran B; Amini M; Oroojalian F; Hashemzaei M; Mokhtarzadeh A; Hamblin MR
Gene; 2021 Feb; 769():145224. PubMed ID: 33059027
[TBL] [Abstract][Full Text] [Related]
47. Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer.
Zhu LF; Song LD; Xu Q; Zhan JF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5122-5132. PubMed ID: 31298365
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
49. lncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells.
Zhou F; Wang J; Chi X; Zhou X; Wang Z
Cancer Manag Res; 2020; 12():5527-5536. PubMed ID: 32765064
[TBL] [Abstract][Full Text] [Related]
50. lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway.
Liu Y; Liu X; Zhang X; Deng J; Zhang J; Xing H
Cancer Manag Res; 2020; 12():2685-2695. PubMed ID: 32368147
[TBL] [Abstract][Full Text] [Related]
51. MCM3AP-AS1 KD Inhibits Proliferation, Invasion, and Migration of PCa Cells via DNMT1/DNMT3 (A/B) Methylation-Mediated Upregulation of NPY1R.
Li X; Lv J; Liu S
Mol Ther Nucleic Acids; 2020 Jun; 20():265-278. PubMed ID: 32193153
[TBL] [Abstract][Full Text] [Related]
52. DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.
Wu Q; Ma J; Meng W; Hui P
Cancer Biol Ther; 2020; 21(1):17-25. PubMed ID: 31591939
[TBL] [Abstract][Full Text] [Related]
53. LncRNA SLC7A11-AS1 stabilizes CTCF by inhibiting its UBE3A-mediated ubiquitination to promote melanoma metastasis.
Yu L; Li J; Xiao M
Am J Cancer Res; 2023; 13(12):6256-6269. PubMed ID: 38187043
[TBL] [Abstract][Full Text] [Related]
54. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
55. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation.
Wang W; Chen G; Wang B; Yuan Z; Liu G; Niu B; Chen Y; Zhou S; He J; Xue H
J Transl Med; 2019 Dec; 17(1):421. PubMed ID: 31847842
[TBL] [Abstract][Full Text] [Related]
56. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
[TBL] [Abstract][Full Text] [Related]
57. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
[TBL] [Abstract][Full Text] [Related]
58. Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer.
Su W; Xu M; Chen X; Chen N; Gong J; Nie L; Li L; Li X; Zhang M; Zhou Q
Mol Cancer; 2017 Aug; 16(1):142. PubMed ID: 28830551
[TBL] [Abstract][Full Text] [Related]
59. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
60. Research progress of DLX6-AS1 in human cancers.
Luo Y; Ge P; Wang M; Chen H; Liu J; Wei T; Jiang Y; Qu J; Chen H
Hum Cell; 2021 Nov; 34(6):1642-1652. PubMed ID: 34508305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
